Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Safety Interaction Trial of Ibudilast With Methamphetamine

NCT01217970 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01217970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Safety Interaction Trial of Ibudilast With Methamphetamine
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
March 31, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine-dependence, substance abuse